On February 21, 2024 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported that management will be participating in the following investor and scientific conferences (Press release, Gritstone Bio, FEB 21, 2024, View Source [SID1234640324]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2024 BIO CEO & Investor Conference (Panel)
Panel Title: Reviewing Vaccine Pipeline Breakthroughs and Barriers
Date and Time: Monday, February 26, 2024 at 2:00pm ET
Location: New York, NY

IO360 Summit (Panel)
Panel Title: How to use AI to Leverage Data from Patients in the Clinic to Iterate Next Gen Immunotherapies
Date and Time: Tuesday, February 27, 2024 at 2:30pm ET
Location: New York, NY

44th Annual TD Cowen Healthcare Conference (Panel)
Panel Title: Novel I-O Corporate Panel
Date and Time: Monday, March 4, 2024 at 10:30am ET
Location: Boston, MA

World Vaccine Congress 2024 (Panel and Presentation)
Panel Title: Exploring the Future Prospects of Cancer Vaccines
Panel Date and Time: Monday, April 3, 2024 at 9:10am ET
Location: Washington, DC

Relevant events will be webcast live and available via View Source Archived replays will be accessible for 30 days following each event.